Rogaratinib: A potent and selective pan-FGFR inhibitor with broad antitumor activity in FGFR-overexpressing preclinical cancer models
罗加替尼:一种强效、选择性泛 FGFR 抑制剂,在 FGFR 过表达的临床前癌症模型中具有广泛的抗肿瘤活性
期刊:International Journal of Cancer
影响因子:5.7
doi:10.1002/ijc.32224
Sylvia Grünewald, Oliver Politz, Sebastian Bender, Mélanie Héroult, Klemens Lustig, Uwe Thuss, Christoph Kneip, Charlotte Kopitz, Dieter Zopf, Marie-Pierre Collin, Ulf Boemer, Stuart Ince, Peter Ellinghaus, Dominik Mumberg, Holger Hess-Stumpp, Karl Ziegelbauer